# Metal-induced cell-level changes in prostate epithelium and cancer risk

> **NIH VA I01** · CENTRAL ARKANSAS VETERANS HLTHCARE SYS · 2023 · —

## Abstract

1 Data in the Veterans Affairs (VA) Central Cancer Registry showed nearly 50,000 new cases of
 2 cancers were diagnosed in the VA system in 2010, and prostate cancer (PCa) is the most frequently
 3 diagnosed cancer among male veterans, with ~12,500 cases or 33% of all cancers reported.
 4 Inhalation or ingestion of toxic air from incomplete combustion are known to increase exposure
 5 to metal ion including lead (Pb) and arsenic (iAs), especially when a great variety of materials
 6 were being burnt in burnpit. iAs and/or Pb exposure have been considered as potential risk factors
 7 for this cancer, but the underlying mechanism is largely undefined. In a small clinical study, we
 8 found that iAs and Pb levels were significantly higher in the urine of PCa patients. Using a new 2-
 9 hit animal model we established, exposure to iAs or Pb was showed to increase (1) PCa risk in
10 vivo, and (2) the ability of prostate epithelial stem-like cells (PrESLCs) isolated from treated
11 animals to form colonies in soft agar, a hallmark of cellular transformation. In this animal model,
12 a 1-month metal treatment followed by chemical carcinogen treatment, resulted in significant
13 increases in PCa incidence and pre-cancerous lesions in iAs-treated animal and trends of increases
14 in Pb-treated animals. Importantly, single-cell RNAseq analyses revealed that Pb was associated
15 with the expansion of a subpopulation of PrESLCs with epithelial lineage markers into stroma-
16 like oncogenic cells, while iAs was associated with the emergence of a rare, unique subpopulation
17 of oncogenic PrESLCs similar to “cancer” stem cells. This application will test the hypothesis that
18 iAs and/or Pb dysregulate specific, and likely different, signaling pathways in subpopulations of
19 prostate epithelial stem-like cells (PrESLCs) to initiate or increase the risk of carcinogenesis in the
20 gland. This is an untested hypothesis in the field of prostate carcinogenesis and in military veterans’
21 health. Two Aims were proposed: 1) Determine the carcinogenic potential of metal-treated prostate
22 epithelial stem-like cells (PrESLCs) in vivo using a renal grafting model of PCa formation assay.
23 We will evaluate the effects of metals on to form PCa in vivo in immune-deficient host mice, either
24 with or without chemical induction of PCa; and 2) Characterize stem-like cells with metal-specific
25 transcriptomic signatures. We will use single-cell RNA sequencing and visualization informatics
26 to identify the unique gene signatures that characterize rare subpopulations of metal-induced
27 cancer stem cells within the PrESLCs population. We aim to apply these gene signatures to enrich
28 rare subpopulations by FACS and evaluate their carcinogenic potential. We will also leverage The
29 Cancer Genome Atlas PCa data and other online databases to enable accurate classification of
30 major, rare, and heterogeneous subtypes of PrESLCs to gain insights in metal carcinogenesis.
3...

## Key facts

- **NIH application ID:** 10664831
- **Project number:** 5I01BX005395-03
- **Recipient organization:** CENTRAL ARKANSAS VETERANS HLTHCARE SYS
- **Principal Investigator:** Shuk-Mei Ho
- **Activity code:** I01 (R01, R21, SBIR, etc.)
- **Funding institute:** VA
- **Fiscal year:** 2023
- **Award amount:** —
- **Award type:** 5
- **Project period:** 2021-07-01 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10664831

## Citation

> US National Institutes of Health, RePORTER application 10664831, Metal-induced cell-level changes in prostate epithelium and cancer risk (5I01BX005395-03). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10664831. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
